InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

W7L Insider Trading

Insider Ownership Percentage: 50.86%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): £342,101.50

Warpaint London Insider Trading History Chart

This chart shows the insider buying and selling history at Warpaint London by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Warpaint London Share Price & Price History

Current Price: GBX 485
Price Change: ▼ Price Decrease of -5 (-1.02%)
As of 04/25/2024 01:00 AM ET

This chart shows the closing price history over time for W7L up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

Warpaint London Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/20/2023Neil RodolInsiderSell105,262GBX 325£342,101.50
6/27/2022Keith SadlerInsiderBuy9,294GBX 129£11,989.26
3/11/2022Keith SadlerInsiderBuy3,629GBX 132£4,790.28
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Warpaint London (LON:W7L)

31.53% of Warpaint London stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Warpaint London logo
Warpaint London PLC, together with its subsidiaries, provides color cosmetics. It operates through two segments, Branded and Close-Out. The company offers its cosmetic skincare products under the W7, Technic, Man'stuff, Body Collection, Very Vegan, and Chit Chat brand names. It also provides supply chain management services. Warpaint London PLC sells its products to retailers, distributors, supermarkets, and retail chains, as well as through online. The company operates in the United Kingdom, rest of Europe, Spain, Denmark, the United States, Australia, New Zealand, and internationally. The company was founded in 1992 and is based in Iver, the United Kingdom.
Read More on Warpaint London

Today's Range

Now: GBX 485
Low: 482.30
High: 500

50 Day Range

MA: GBX 409.23
Low: 375
High: 492.50

52 Week Range

Now: GBX 485
Low: 199.52
High: 506

Volume

248,015 shs

Average Volume

158,565 shs

Market Capitalization

£374.71 million

P/E Ratio

4,409.09

Dividend Yield

1.80%

Beta

0.73

Who are the company insiders with the largest holdings of Warpaint London?

Warpaint London's top insider shareholders include:
  1. Keith Sadler (Insider)
  2. Neil Rodol (Insider)
Learn More about top insider investors at Warpaint London.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...